Project The required tasks are detailed below:

(1) Prepare A common-size analysis [for 3 consecutive years]: Vertical analysis is performed for the income statement and balance sheet with comments Horizontal analysis is performed for the income statement, balance sheet, and cash flow statement with comments 2) A Ratio analysis for each Company [for two consecutive years]: Comprehensive analysis and comments on the improvement and/or the deterioration of the companys liquidity. Profitability, market, solvency, and efficiency in the two years

CONSOLIDATED STATEMENTS OF OPERATIONS (In millions, except number of shares which are reflected in thousands and per share amounts) Years ended September 28, September 29, September 30, 2019 2018 2017 Net sales: Products Services Total net sales 213,883 $ 46,291 260,174 225,847 $ 39,748 265,595 196,534 32,700 229,234 Cost of sales: Products Services Total cost of sales Gross margin 144,996 16,786 161,782 98,392 148,164 15,592 163,756 101,839 126,337 14,711 141,048 88,186 Operating expenses: Research and development Selling, general and administrative Total operating expenses 16,217 18,245 34,462 14,236 16,705 30,941 11,581 15,261 26,842 Operating income Other income/expense), net Income before provision for income taxes Provision for income taxes Net income 63,930 1,807 65,737 10,481 55,256 $ 70,898 2,005 72,903 13,372 59,531 $ 61,344 2,745 64,089 15,738 48,351 Earnings per share: Basic Diluted $ 11.97 $ 11.89 $ 12.01 $ 11.91 $ 9.27 9.21 Shares used in computing earnings per share: Basic Diluted 4,617,834 4,648,913 4,955,377 5,000,109 5,217.242 5,251,692 Years ended September 28, September 29, September 30, 2019 2018 2017 $ 55,256 $ 59,531 5 48,351 Net income Other comprehensive income/(loss): Change in foreign currency translation, net of tax (408) (525) 224 (661) 523 1,315 Change in unrealized gains/losses on derivative instruments, net of tax: Change in fair value of derivatives Adjustment for net (gains)/losses realized and included in net income Total change in unrealized gains/losses on derivative instruments 23 382 (1,477) (638) 905 (162) 3,802 (3,407) (782) Change in unrealized gains/losses on marketable securities, net of tax: Change in fair value of marketable securities Adjustment for net (gainsy/losses realized and included in net income Total change in unrealized gains/losses on marketable securities 25 1 (64) 3,827 (3,406) (846) Total other comprehensive income/loss) Total comprehensive income 2,781 58,037 $ (3,026) 56,505 $ (784) 47,567 $ See accompanying Notes to Consolidated Financial Statements. CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (In millions, except per share amounts) Years ended September 28, September 29, September 30, 2019 2018 2017 $ 107,147 S 134,047 $ 128,249 Total shareholders' equity, beginning balances 40,201 781 35,867 669 31,251 555 Common stock and additional paid-in capital: Beginning balances Common stock issued Common stock withheld related to net share settlement of equity awards Share-based compensation Tax benefit from equity awards, including transfer pricing adjustments Ending balances (2,002) 6,194 (1.778) 5,443 (1,468) 4,909 45,174 40,201 620 35,867 70,400 55,256 (14,129) 98,330 59,531 (13,735) 96,364 48,351 (12,803) Retained earnings: Beginning balances Net income Dividends and dividend equivalents declared Common stock withheld related to net share settlement of equity awards Common stock repurchased Cumulative effects of changes in accounting principles Ending balances (581) (33,001) (1,029) (67,101) 2,501 45,898 (948) (73,056) 278 70,400 98,330 Accumulated other comprehensive income/(loss): Beginning balances Other comprehensive income/loss) Cumulative effects of changes in accounting principles Ending balances 634 (784) (3,454) 2,781 89 (584) (150) (3,026) (278) (3,454) (150) Total shareholders' equity, ending balances $ 90,488 $ 107,147 $ 134,047 Dividends and dividend equivalents declared per share or RSU 3.00 $ 2.72 $ 2.40 See accomanvin Notee to consolidated Financial Statemente CONSOLIDATED BALANCE SHEETS (In millions, except number of shares which are reflected in thousands and par value) September 28, 2019 September 29, 2018 ASSETS: Current assets. Cash and cash equivalents Marketable securities Accounts receivable, net Inventories Vendor non-trade receivables Other current assets Total current assets 48,844 $ 51,713 22,926 4,106 22,878 25,913 40,388 23,186 3,956 25.809 12,087 131,339 12,352 162,819 Non-current assets: Marketable securities Property, plant and equipment, net Other non-current assets Total non-current assets Total assets 105,341 37,378 32,978 175,697 338,516 170,799 41,304 22,283 234,386 365,725 $ $ LIABILITIES AND SHAREHOLDERS' EQUITY: $ Current liabilities: Accounts payable Other current liabilities Deferred revenue Commercial paper Temm debt Total current liabilities 46,236 $ 37,720 5,522 5,980 10.260 55,888 33,327 5,966 11,964 8,784 115,929 105,718 Non-current liabilities: Tem debt Other non-current liabilities Total non-current liabilities Total liabilities 93,735 48.914 91,807 50,503 142,310 248,028 142,649 258,578 Commitments and contingencies Shareholders' equity: Common stock and additional paid-in capital, $0.00001 par value: 12,600,000 shares authorized: 4,443,236 and 4,754,986 shares issued and outstanding, respectively Retained earnings Accumulated other comprehensive income/loss) Total shareholders' equity Total liabilities and shareholders' equity 45,174 45,898 (584) 90,488 338,516 S 40,201 70,400 (3,454) 107,147 365,725 $ See accompanying Notes to consolidated Financial statemente CONSOLIDATED STATEMENTS OF CASH FLOWS (In millions) Years ended September 28, 2019 September 29, 2018 September 30, 2017 25,913 20,289 $ 20,484 55,256 59,531 48,351 12,547 6,068 (340) (652) 10,903 5,340 (32,590) (444) 10,157 4,840 5,966 (166) 245 (289) 2,931 873 (1,923) (625) (4,700) 69,391 (5,322) 828 (8,010) (423) 9,175 (3) 38,449 77,434 (2,093) (2,723) (4,254) (5,318) 8,966 (593) 1,092 64,225 Cash, cash equivalents and restricted cash, beginning balances Operating activities: Net income Adjustments to reconcile net income to cash generated by operating activities: Depreciation and amortization Share-based compensation expense Deferred income tax expense/(benefit) Other Changes in operating assets and liabilities: Accounts receivable, net Inventories Vendor non-trade receivables Other current and non-current assets Accounts payable Deferred revenue Other current and non-current liabilities Cash generated by operating activities Investing activities: Purchases of marketable securities Proceeds from maturities of marketable securities Proceeds from sales of marketable securities Payments for acquisition of property, plant and equipment Payments made in connection with business acquisitions, net Purchases of non-marketable securities Proceeds from non-marketable securities Other Cash generated by/(used in) investing activities Financing activities: Proceeds from issuance of common stock Payments for taxes related to net share settlement of equity awards Payments for dividends and dividend equivalents Repurchases of common stock Proceeds from issuance of term debt, net Repayments of term debt Proceeds from/(Repayments of) commercial paper, net Other Cash used in financing activities (39,630) 40,102 (71,356) 55,881 56,988 47,838 (10,495) (624) (1,001) 1,634 (1,078) 45,896 (13,313) (721) (1,871) 353 (745) 16,066 (159,486) 31,775 94,564 (12,451) (329) (521) 126 (124) (46,446) 669 781 (2,817) (14,119) (66,897) 6,963 (8,805) (5,977) (105) (90,976) (2,527) (13,712) (72,738) 6,969 (6,500) (37) 555 (1.874) (12,769) (32,900) 28,662 (3,500) 3,852 (87,876) 5,624 24,311 50,224 $ (17,974) (195) 20,289 $ 25,913 $ Increase/(Decrease) in cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash, ending balances Supplemental cash flow disclosure: Cash paid for income taxes, net Cash paid for interest $ $ 15,263 3,423 10,417 3,022 11,591 2,092 $ $